Brief: Invex Therapeutics Says Signs Long Term Collaboration And Manufacturing Agreement With Peptron, Inc.
Sept 27 (Reuters) - Invex Therapeutics Ltd IXC.AX :
* SIGNING OF A LONG TERM COLLABORATION AND MANUFACTURING
AGREEMENT
WITH PEPTRON, INC.
* PEPTRON TO PROVIDE CO WITH ACCESS TO ITS IP, INCLUDING AN
EXTENSIVE PRECLINICAL AND CLINICAL DATA PACKAGE, AMONG OTHERS
* GRANTED PEPTRON AN EXCLUSIVE LICENSE TO COMMERCIALISE IT
FOR
IDIOPATHIC INTRACRANIAL HYPERTENSION IN KOREA
Source text for Eikon: ID:nASX7KB7nN
Further company coverage: 087010.KQ
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Peptron
See all newsBrief: Peptron To Divest 24 Billion Won Worth Of Own Shares
Brief: Peptron To Invest 65 Billion Won In New Factory
Brief: Peptron To Conduct Capital Increase Of 120 Billion Won
Australia's Invex Therapeutics drops on ending contract with Peptron
Brief: Peptron's Pt105 Established Bioequivalence With Takeda's Leuplin